Showing 38,481 - 38,500 results of 113,916 for search '(( 6 b decrease ) OR ( 5 ((((wt decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.96s Refine Results
  1. 38481
  2. 38482

    Contribution of the LysM domain to septum cleavage. by Bartłomiej Salamaga (4268947)

    Published 2017
    “…<b>E</b>. Comparison of median forward scattered (FSC) light values corresponding to the cell chain lengths of WT, <i>atlA</i><sub>1-5</sub>, <i>atlA</i><sub>1-4</sub>, <i>atlA</i><sub>1-3</sub>, <i>atlA</i><sub>1-2</sub>, <i>atlA</i><sub>1</sub> and Δ<i>atlA</i> strains. …”
  3. 38483

    Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan by Shinichi Matsuda (733301)

    Published 2015
    “…The High frequency:Low frequency ratio for peginterferon alpha-2a and sevelamer hydrochloride decreased steadily throughout the study period.…”
  4. 38484

    CD31 Western blot for naive, AAV5+/−decorin-delivered rabbit corneal tissues collected 10 and 14 days after VEGF-implantation. by Rajiv R. Mohan (48994)

    Published 2013
    “…<p>Panel on left side shows immunoblot and on right side shows quantification of western blotting data collected from corneal tissues of day-10 and day-14. A significant decrease in expression of CD31 on day-10 (62%, p<0.05) and day-14 (66%, p<0.05) was detected in decorin-delivered corneas compared to control corneas suggesting that AAV5-mediated decorin gene therapy is efficient in decreasing CNV. β-actin was used to confirm equal loading of protein in each well and normalization of the data. dcn = decorin.…”
  5. 38485

    Image1_The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients.JPEG by Jing Wang (6206297)

    Published 2023
    “…</p><p>Results: During belimumab treatment, SLEDAI-2K declined, the proportions of CD19<sup>+</sup> B cells and naïve B cells decreased, whereas the switched memory B cells and non-switched B cells increased. …”
  6. 38486

    Table1_The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients.DOCX by Jing Wang (6206297)

    Published 2023
    “…</p><p>Results: During belimumab treatment, SLEDAI-2K declined, the proportions of CD19<sup>+</sup> B cells and naïve B cells decreased, whereas the switched memory B cells and non-switched B cells increased. …”
  7. 38487

    Ductal branching is dependent upon phenotype heterogeneity within MCF10A in 3-D culture. by Russell Gould (3603524)

    Published 2016
    “…C = Control, T = TGF−<i>β</i>2, V = VEGFA, VI = NFAT inhibitor (VIVIT). Asterisks signify statistical differences from each other according to a one-way ANOVA with Tukey’s post hoc (p≺0.05). …”
  8. 38488

    Inhibition of <i>Tityus serrulatus</i> venom hyaluronidase affects venom biodistribution by Bárbara Bruna Ribeiro de Oliveira-Mendes (6551183)

    Published 2019
    “…A higher concentration of immunoneutralized <sup>99m</sup>Tc-TsV was observed in the kidneys in comparison with the non-treated venom. …”
  9. 38489
  10. 38490
  11. 38491

    S1 Dataset - by Gui-Hong Zhang (9284601)

    Published 2023
    “…Tβ4 alleviated oxidative damage by reducing MDA, LDH and ROS and increasing SOD and GSH-PX in Aβ-treated SH-SY5Y cells. We found that Tβ4 inhibit ERK/p38 MAPK pathway and intensify the expression of 5-HTR1A. …”
  12. 38492

    Image_5_Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019.tif by Yaguang Fan (15415049)

    Published 2023
    “…Decomposition analysis was used to analyze the contributions of epidemiological and demographic drivers to lung cancer mortality.</p>Results<p>Despite a non-significant decrease in ASMR [EAPC = −0.31, 95% confidence interval (CI): −1.1 to 0.49], the number of deaths from lung cancer increased by 91.8% [95% uncertainty interval (UI): 74.5–109.0%] between 1990 and 2019. …”
  13. 38493

    Evaluation of the Oxygen π-Donation in Permethyltitanocene Silanolates and Alcoholates by Vojtech Varga (2267647)

    Published 2009
    “…A series of compounds [Cp*<sub>2</sub>Ti(III)OR′] where R′ is <sup><i>i</i></sup>Pr<sub>3</sub>Si (<b>2</b>), Ph<sub>3</sub>Si (<b>3</b>), (<sup><i>t</i></sup>BuO)<sub>3</sub>Si (<b>4</b>), (<i>c</i>-C<sub>5</sub>H<sub>9</sub>)<sub>7</sub>Si<sub>8</sub>O<sub>12</sub> (<b>5</b>), and <sup><i>t</i></sup>Bu (<b>6</b>) were prepared by protolysis of the titanium−methylene bond in singly tucked-in permethyltitanocene [Cp*Ti(III)(η<sup>5</sup>:η<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>)] with the respective silanols or <i>tert</i>-butanol. …”
  14. 38494

    Simulated tuning curves of nearness and farness cells. by Jiehui Qian (294581)

    Published 2015
    “…<p>The cell tuning curves in V1 are simulated by Gaussians. Similar to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129377#pone.0129377.g001" target="_blank">Fig 1a and 1b</a> in Dobbins et al [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129377#pone.0129377.ref010" target="_blank">10</a>], the magnitudes of the responses of nearness (farness) cells decrease (increase) with viewing distance (Distance 1 < Distance 2 < Distance 3), but the shape and position of the peaks of the tuning curves are similar.…”
  15. 38495

    PCR Primers. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  16. 38496

    Suggested model. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  17. 38497

    Mouse antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  18. 38498

    Human antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  19. 38499

    Meta-analysis of laparoscopic vs. open resection of gastric gastrointestinal stromal tumors by Liangying Ye (4015070)

    Published 2017
    “…The LAP patients also exhibited a decrease in overall complications (P<0.01). In addition, regarding the subgroup of larger GISTs (>5 cm), the present study did not report significant differences in operation time (P = 0.93), postoperative complications (P = 0.30), or recurrence rate (P = 0.61) between the two groups, though LAP was associated with favorable results regarding blood loss (P = 0.03) and hospital stay (P<0.01).…”
  20. 38500

    Torque response of DNA loaded with (H3.3-H4)<sub>2</sub> tetrasomes. by Rifka Vlijm (133750)

    Published 2015
    “…(B) The torque stored in DNA loaded with 5 tetrasomes plotted as a function of the number of applied rotations, <i>θ</i>. …”